Latest Insider Transactions at Colgate Palmolive CO (CL)
This section provides a real-time view of insider transactions for Colgate Palmolive CO (CL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COLGATE PALMOLIVE CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COLGATE PALMOLIVE CO's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 08
2021
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-4.79%
|
$25,949
$77.76 P/Share
|
Nov 15
2021
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8
-0.03%
|
$624
$78.3 P/Share
|
Nov 09
2021
|
Stanley J Sutula Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,704
-6.08%
|
$132,912
$78.05 P/Share
|
Nov 08
2021
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
576
-7.67%
|
$44,352
$77.14 P/Share
|
Nov 05
2021
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
100,000
-29.44%
|
$7,700,000
$77.4 P/Share
|
Nov 05
2021
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+22.74%
|
$6,800,000
$68.98 P/Share
|
Nov 04
2021
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
145,200
-37.72%
|
$11,180,400
$77.18 P/Share
|
Nov 04
2021
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
152,809
+28.42%
|
$10,391,012
$68.98 P/Share
|
Nov 03
2021
|
Stephen I Sadove Director |
SELL
Bona fide gift
|
Indirect |
13,000
-65.32%
|
-
|
Nov 03
2021
|
Stephen I Sadove Director |
BUY
Bona fide gift
|
Indirect |
13,000
+50.0%
|
-
|
Oct 01
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
276
+1.3%
|
$20,976
$76.91 P/Share
|
Oct 01
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
276
+1.18%
|
$20,976
$76.91 P/Share
|
Sep 14
2021
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
635
-7.8%
|
$48,895
$77.18 P/Share
|
Sep 14
2021
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
610
-7.69%
|
$46,970
$77.18 P/Share
|
Aug 16
2021
|
Philip G. Shotts Vice President and Controller |
SELL
Open market or private sale
|
Direct |
12,737
-22.74%
|
$1,006,223
$79.95 P/Share
|
Aug 16
2021
|
Philip G. Shotts Vice President and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,737
+18.53%
|
$776,957
$61.93 P/Share
|
Aug 05
2021
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
20,290
-33.46%
|
$1,602,910
$79.11 P/Share
|
Aug 05
2021
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,290
+25.07%
|
$1,460,880
$72.99 P/Share
|
Aug 04
2021
|
Lorrie M Norrington Director |
SELL
Open market or private sale
|
Direct |
1,898
-7.71%
|
$148,044
$78.02 P/Share
|
Aug 04
2021
|
Lorrie M Norrington Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,898
+7.16%
|
$127,166
$67.48 P/Share
|
Jul 01
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
258
+1.24%
|
$21,156
$82.33 P/Share
|
Jul 01
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
258
+1.12%
|
$21,156
$82.33 P/Share
|
May 10
2021
|
Kimberly A Nelson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,799
+50.0%
|
-
|
May 10
2021
|
Martina Hundmejean Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+36.35%
|
-
|
May 10
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+8.82%
|
-
|
May 10
2021
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+23.97%
|
-
|
May 10
2021
|
Stephen I Sadove Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,159
+9.79%
|
-
|
May 10
2021
|
Michael B Polk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+9.56%
|
-
|
May 10
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+9.64%
|
-
|
May 10
2021
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+9.96%
|
-
|
May 10
2021
|
John T Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+7.83%
|
-
|
May 10
2021
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
5,733
-42.15%
|
$475,839
$83.67 P/Share
|
May 10
2021
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,733
+29.65%
|
$412,776
$72.99 P/Share
|
May 10
2021
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
20,289
-33.48%
|
$1,663,698
$82.62 P/Share
|
May 10
2021
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,289
+25.08%
|
$1,460,808
$72.99 P/Share
|
May 06
2021
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
11,195
-58.15%
|
$917,990
$82.07 P/Share
|
May 06
2021
|
John W Kooyman Chief of Staff |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.19%
|
$610,000
$61.93 P/Share
|
May 05
2021
|
John P Bilbrey Director |
SELL
Open market or private sale
|
Direct |
3,941
-17.89%
|
$315,280
$80.95 P/Share
|
May 05
2021
|
John P Bilbrey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,652
+17.44%
|
$311,684
$67.83 P/Share
|
May 05
2021
|
Patricia Verduin SVP, Global Technology |
SELL
Open market or private sale
|
Direct |
46,566
-46.25%
|
$3,725,280
$80.89 P/Share
|
May 05
2021
|
Patricia Verduin SVP, Global Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
46,566
+31.62%
|
$2,840,526
$61.93 P/Share
|
May 05
2021
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
25,279
-9.83%
|
$2,047,599
$81.03 P/Share
|
May 05
2021
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,279
+8.95%
|
$1,542,019
$61.93 P/Share
|
May 05
2021
|
Stephen I Sadove Director |
SELL
Open market or private sale
|
Indirect |
8,000
-31.08%
|
$648,000
$81.3 P/Share
|
Apr 01
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.3%
|
$17,328
$76.48 P/Share
|
Apr 01
2021
|
Helene D Gayle Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.07%
|
$17,328
$76.48 P/Share
|
Apr 01
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
212
+1.04%
|
$16,112
$76.48 P/Share
|
Feb 18
2021
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
BUY
Grant, award, or other acquisition
|
Direct |
6,922
+40.54%
|
-
|
Feb 18
2021
|
Prabha Parameswaran Grp Pres, Growth & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
6,922
+42.39%
|
-
|
Feb 18
2021
|
Jennifer Daniels CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,922
+14.65%
|
-
|